da agonists with different receptor action than da produce beneficial hemodynamic effects in patients with chf : propylbutyl-da ( da1 and da2 receptors ) , bromocriptine ( da2 receptors ) , fenoldopam ( da1 receptors ) , and dopexamine ( da1 and da2 receptors , and beta 2-adrenoceptors ) .
C0018802
chf
C0060180
fenoldopam